ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000261613.2	Nilotinib	Breast invasive carcinoma	0.026242526	Resistant
ENSG00000261613.2	Nilotinib	Head and neck squamous cell carcinoma	0.043602344	Resistant